Jeffrey P Norenberg
Overview
Explore the profile of Jeffrey P Norenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
519
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rai G, Urban D, Mott B, Hu X, Yang S, Benavides G, et al.
J Med Chem
. 2020 Sep;
63(19):10984-11011.
PMID: 32902275
Lactate dehydrogenase (LDH) catalyzes the conversion of pyruvate to lactate, with concomitant oxidation of reduced nicotinamide adenine dinucleotide as the final step in the glycolytic pathway. Glycolysis plays an important...
2.
Kennedy D, Harrell T, Lodise N, Mattingly 2nd T, Norenberg J, Ragucci K, et al.
Am J Pharm Educ
. 2020 Aug;
84(7):ajpe7281.
PMID: 32773821
To characterize shared governance in US schools and colleges of pharmacy and recommend best practices to promote faculty engagement and satisfaction. The literature review revealed only one study on governance...
3.
Barrett H, Meester E, van Gaalen K, van der Heiden K, Krenning B, Beekman F, et al.
Eur J Nucl Med Mol Imaging
. 2020 Apr;
47(12):2856-2865.
PMID: 32291511
Purpose: Atherosclerotic plaque development and progression signifies a complex inflammatory disease mediated by a multitude of proinflammatory leukocyte subsets. Using single photon emission computed tomography (SPECT) coupled with computed tomography...
4.
Oshima N, Ishida R, Kishimoto S, Beebe K, Brender J, Yamamoto K, et al.
Cell Rep
. 2020 Feb;
30(6):1798-1810.e4.
PMID: 32049011
The reliance of many cancers on aerobic glycolysis has stimulated efforts to develop lactate dehydrogenase (LDH) inhibitors. However, despite significant efforts, LDH inhibitors (LDHi) with sufficient specificity and in vivo...
5.
Noor S, Sanchez J, Sun M, Pervin Z, Sanchez J, Havard M, et al.
Brain Behav Immun
. 2020 Jan;
87:339-358.
PMID: 31918004
Previous reports show that moderate prenatal alcohol exposure (PAE) poses a risk factor for developing neuropathic pain following adult-onset peripheral nerve injury in male rats. Recently, evidence suggests that immune-related...
6.
Noor S, Sun M, Vanderwall A, Havard M, Sanchez J, Harris N, et al.
Neuroimmunol Neuroinflamm
. 2019 Nov;
6.
PMID: 31763376
Aim: The majority of preclinical studies investigating aberrant glial-neuroimmune actions underlying neuropathic pain have focused on male rodent models. Recently, studies have shown peripheral immune cells play a more prominent...
7.
Mota R, Campen M, Cuellar M, Garver W, Hesterman J, Qutaish M, et al.
Contrast Media Mol Imaging
. 2018 Dec;
2018:6508724.
PMID: 30538613
Atherosclerosis-related morbidity and mortality remain a global concern. Atherosclerotic disease follows a slow and silent progression, and the transition from early-stage lesions to vulnerable plaques remains difficult to diagnose. Inflammation...
8.
Ghai A, Singh B, Li M, Daniels T, Coelho R, Orcutt K, et al.
Appl Radiat Isot
. 2018 Aug;
140:333-341.
PMID: 30138815
In the present study, the effect of radiolabeling conditions on radiolabeling efficiency and achievable specific activity of a DOTA-conjugated highly-lipophilic peptide containing three disulfide cyclization bonds was examined. The peptide...
9.
Chan H, de Blois E, Konijnenberg M, Morgenstern A, Bruchertseifer F, Norenberg J, et al.
EJNMMI Radiopharm Chem
. 2018 Mar;
1(1):9.
PMID: 29564386
Background: Bismuth (Bi, T = 45.6 min) is one of the most frequently used α-emitters in cancer research. High specific activity radioligands are required for peptide receptor radionuclide therapy. The...
10.
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
Makvandi M, Dupis E, Engle J, Nortier F, Fassbender M, Simon S, et al.
Target Oncol
. 2018 Feb;
13(2):189-203.
PMID: 29423595
Alpha-emitters are radionuclides that decay through the emission of high linear energy transfer α-particles and possess favorable pharmacologic profiles for cancer treatment. When coupled with monoclonal antibodies, peptides, small molecules,...